日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot Study

从颈肌张力障碍患者身上汲取肉毒杆菌毒素A疗法的经验教训:疾病进程的初步研究

Hefter, Harald; Schomaecker, Isabelle; Schomaecker, Max; Ürer, Beyza; Brauns, Raphaela; Rosenthal, Dietmar; Albrecht, Philipp; Samadzadeh, Sara

The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation-A Monocentric Cross-Sectional Pilot Study

使用高初始剂量肉毒杆菌毒素治疗颈肌张力障碍是中和抗体形成的一个风险因素——一项单中心横断面试点研究

Hefter, Harald; Schomaecker, Isabelle; Schomaecker, Max; Rosenthal, Dietmar; Samadzadeh, Sara

Rational design of tandem catalysts using a core-shell structure approach

利用核壳结构方法合理设计串联催化剂

Gioria, Esteban; Duarte-Correa, Liseth; Bashiri, Najmeh; Hetaba, Walid; Schomaecker, Reinhard; Thomas, Arne

The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia

肉毒杆菌毒素治疗前疾病进程对颈肌张力障碍治疗过程和长期预后的影响

Hefter, Harald; Schomaecker, Isabelle; Schomaecker, Max; Rosenthal, Dietmar; Samadzadeh, Sara

Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach

Pentixafor PET/CT 用于食管癌趋化因子受体 4 表达的成像 - 首个临床方法

Philipp Linde, Christian Baues, Simone Wegen, Maike Trommer, Alexander Quaas, Johannes Rosenbrock, Eren Celik, Simone Marnitz, Christiane J Bruns, Thomas Fischer, Klaus Schomaecker, Hans-Juergen Wester, Alexander Drzezga, Lutz van Heek, Carsten Kobe

Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy

尽管肉毒杆菌毒素治疗后病情有所改善,但特发性颈肌张力障碍的疾病仍会进展。

Hefter, Harald; Schomaecker, Isabelle; Schomaecker, Max; Samadzadeh, Sara